Clinical Context
A typical patient is an adolescent or adult with convergence insufficiency, accommodative dysfunction, or binocular vision disorders who is prescribed an FDA-cleared, software-only, prescription digital visual therapy program for a defined course of treatment. The patient has an evaluation by an optometrist or ophthalmologist documenting symptoms (e.g., diplopia, eye strain, difficulty reading) and baseline clinical measures (near point of convergence, positive fusional vergence, accommodative amplitude). The clinician documents medical necessity, selects the appropriate digital therapy regimen, issues a prescription for the software-only product billed as A9292 per course of treatment, and provides instructions for home or supervised use.
The clinical workflow: the provider performs a diagnostic eye examination, documents the binocular vision diagnosis and treatment plan, prescribes the FDA-cleared software program, and arranges patient access (license key or portal enrollment). The patient completes the prescribed sessions (often daily or several times weekly) over the specified course; progress is monitored by follow-up visits or remote data review. Billing for the software-only prescription uses A9292 once per course of therapy; professional services (evaluation, follow-up) are billed separately using appropriate evaluation and management or ophthalmology/optometry codes and may include modifier 26 when only the professional component is billed or one of the modifiers related to multiple practitioners or technical component responsibilities where applicable.